Perspective Therapeutics (CATX) EBITDA (2010 - 2026)
Perspective Therapeutics (CATX) posted EBITDA of -$28.12 million for Q2 2026, compared with -$23.31 million a year earlier.
Powered by 
Analysis
Perspective Therapeutics (CATX) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Perspective Therapeutics was -$117.74 million; for FY2025, it was -$110.31 million.
- In prior years, Perspective Therapeutics' EBITDA was -$88.58 million in FY2024, -$39.92 million in FY2023, -$8.36 million in FY2022 and -$3.26 million in FY2021.
- Quarterly EBITDA has run from a low of -$44.28 million in Q4 2024 to a high of $103,000 in Q4 2022 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$27.16 million (Q1 2026), -$37.27 million (Q4 2025) and -$25.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Perspective Therapeutics | 279.31 Mn | 42.41 Mn | - | -28.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.12 Mn |
| Mar 31, 2026 | -27.16 Mn |
| Dec 31, 2025 | -37.27 Mn |
| Sep 30, 2025 | -25.19 Mn |
| Jun 30, 2025 | -23.31 Mn |
| Mar 31, 2025 | -21.10 Mn |
| Dec 31, 2024 | -44.28 Mn |
| Sep 30, 2024 | -17.97 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Mar 31, 2024 | -12.64 Mn |
| Dec 31, 2023 | -11.36 Mn |
| Sep 30, 2023 | -9.48 Mn |
| Jun 30, 2023 | -9.49 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | 103,000.00 |
| Sep 30, 2022 | -4.14 Mn |
| Jun 30, 2022 | -2.03 Mn |
| Mar 31, 2022 | -1.29 Mn |
| Dec 31, 2021 | -1.56 Mn |
| Sep 30, 2021 | -2.21 Mn |
API Access
Perspective Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();